MXPA04007250A - 2??-halo-3??, 5??-dialcoxi-fen-1??-il-imino-2-imidazolidinas y su uso como un farmaco. - Google Patents

2??-halo-3??, 5??-dialcoxi-fen-1??-il-imino-2-imidazolidinas y su uso como un farmaco.

Info

Publication number
MXPA04007250A
MXPA04007250A MXPA04007250A MXPA04007250A MXPA04007250A MX PA04007250 A MXPA04007250 A MX PA04007250A MX PA04007250 A MXPA04007250 A MX PA04007250A MX PA04007250 A MXPA04007250 A MX PA04007250A MX PA04007250 A MXPA04007250 A MX PA04007250A
Authority
MX
Mexico
Prior art keywords
imidazolidine
imino
compound according
phen
chloro
Prior art date
Application number
MXPA04007250A
Other languages
English (en)
Spanish (es)
Inventor
Muramatsu Ikunobu
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MXPA04007250A publication Critical patent/MXPA04007250A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA04007250A 2002-01-31 2002-12-16 2??-halo-3??, 5??-dialcoxi-fen-1??-il-imino-2-imidazolidinas y su uso como un farmaco. MXPA04007250A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02002352A EP1333028A1 (en) 2002-01-31 2002-01-31 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
PCT/EP2002/014299 WO2003064398A1 (en) 2002-01-31 2002-12-16 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
MXPA04007250A true MXPA04007250A (es) 2004-10-29

Family

ID=8185397

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04007250A MXPA04007250A (es) 2002-01-31 2002-12-16 2??-halo-3??, 5??-dialcoxi-fen-1??-il-imino-2-imidazolidinas y su uso como un farmaco.

Country Status (20)

Country Link
EP (2) EP1333028A1 (enExample)
JP (1) JP2005516066A (enExample)
KR (1) KR20040074134A (enExample)
CN (1) CN1617857A (enExample)
AR (1) AR038380A1 (enExample)
BR (1) BR0215560A (enExample)
CA (1) CA2474588A1 (enExample)
EA (1) EA200400877A1 (enExample)
EC (1) ECSP045210A (enExample)
HR (1) HRP20040691A2 (enExample)
HU (1) HUP0402654A2 (enExample)
IL (1) IL162776A0 (enExample)
MX (1) MXPA04007250A (enExample)
NO (1) NO20043614L (enExample)
PE (1) PE20030819A1 (enExample)
PL (1) PL369826A1 (enExample)
TW (1) TW200418462A (enExample)
UY (1) UY27628A1 (enExample)
WO (1) WO2003064398A1 (enExample)
ZA (1) ZA200405173B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体
BRPI0912604A2 (pt) * 2008-05-13 2019-09-10 Allergan Inc quinolinilmetilimidazóis como agentes terapêuticos
BRPI0913019A2 (pt) 2008-05-13 2015-10-13 Allergan Inc naftilmetilimidazóis para o tratamento de incontinência urinária por estresse
ES2665293T3 (es) * 2008-06-09 2018-04-25 Allergan, Inc. Compuesto para tratar estados con mediación alfa-adrenérgica
US8063231B2 (en) * 2008-06-09 2011-11-22 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions
US9034910B2 (en) 2008-06-09 2015-05-19 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2220906A1 (de) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2259160A1 (de) * 1972-12-02 1974-06-06 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline, deren saeureadditionssalze und verfahren zur herstellung derselben sowie ihre verwendung als arzneimittel
AT333749B (de) * 1974-07-03 1976-12-10 Chemie Linz Ag Verfahren zur herstellung von neuen 2-arylamino-2-imidazolinderivaten
MTP837B (en) * 1977-11-07 1979-10-22 Hoffman La Roche And Co Aktien Derivatives 2 finino-imidazolidire
DE3514351A1 (de) * 1985-04-20 1986-11-06 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
DE19740176C2 (de) * 1997-09-12 2000-04-06 Lemfoerder Metallwaren Ag Handschaltvorrichtung für ein Kraftfahrzeug

Also Published As

Publication number Publication date
UY27628A1 (es) 2003-08-29
CA2474588A1 (en) 2003-08-07
AR038380A1 (es) 2005-01-12
KR20040074134A (ko) 2004-08-21
CN1617857A (zh) 2005-05-18
ZA200405173B (en) 2005-06-21
TW200418462A (en) 2004-10-01
HRP20040691A2 (en) 2004-12-31
NO20043614L (no) 2004-08-30
ECSP045210A (es) 2004-09-28
EP1472231A1 (en) 2004-11-03
EP1333028A1 (en) 2003-08-06
JP2005516066A (ja) 2005-06-02
HUP0402654A2 (hu) 2005-03-29
IL162776A0 (en) 2005-11-20
WO2003064398A1 (en) 2003-08-07
BR0215560A (pt) 2004-12-21
PE20030819A1 (es) 2003-10-20
EA200400877A1 (ru) 2005-02-24
PL369826A1 (en) 2005-05-02

Similar Documents

Publication Publication Date Title
JP4141763B2 (ja) 新規フェニルイミノイミダゾリジン
EP1249450B1 (en) Benzimidazole derivatives as human chymase inhibitors
MXPA04007250A (es) 2??-halo-3??, 5??-dialcoxi-fen-1??-il-imino-2-imidazolidinas y su uso como un farmaco.
JPH07242626A (ja) 胃酸分泌抑制剤及び抗潰瘍剤
US7176320B2 (en) Benzimidazole derivative
US6703409B2 (en) 2′-Halo-3′,5′-dialkoxyphen-1′-yl-imino-2-imidazolidine and the use thereof as a drug
HUT77907A (hu) 2-Metil-4-(4-metil-piperazino)-1OH-tieno[2,3-b][1,5] benzodiazepin alkalmazása kognitiv diszfunkció kezelésére gyógyszerkészítmények előállítására
AU2002360984A1 (en) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
GB2033900A (en) Sulphonamides
JP2001519828A (ja) α▲下２▼−アドレナリン受容体作動薬として有用な５−（２−イミダゾリニルアミノ）ベンゾイミダゾール化合物類
US3966935A (en) Inhibition of ulcers with 2(3H)-perimidylidene-2-propanone
JP2004517963A (ja) 尿失禁治療用の新規なアルキル−フェニルイミノイミダゾリジン誘導体
IE58204B1 (en) 2-Guanidino-4-(2-methyl-4-imidazolyl) thiazoles in the treatment of rheumatoid arthritis
HK1050009B (en) Benzimidazole derivatives as human chymase inhibitors
EP2626349A1 (en) Amine compound and use for same
JPS63130587A (ja) イミダゾ−ルイソチオ尿素誘導体及びそれらを有効成分とする医薬組成物